Results 101 to 110 of about 128,316 (279)

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated with High Structural Damage in Ankylosing Spondylitis

Arthritis &Rheumatology, Accepted Article.
Objective Pathological bone formation in ankylosing spondylitis (AS) is not fully reflected by systemic inflammation, limiting the utility of inflammatory markers for structural damage assessment. This study aimed to identify plasma protein signatures associated with structural damage severity in AS.
Tiantian Sun, Wanlin Liu, Kun Yang, Xiaohan Xu, Yu Wang, Xinning Qu, Yifan Gong, Wenya Zhang, Jie Ma, Hongxiao Liu   +9 more
wiley   +1 more source

Classification and Prioritization of Health Education Needs Among HPV‑Infected Patients in Chengdu: A KANO Model-Based Cross-Sectional Study

Patient Preference and Adherence
Yuying Zhang, Li Luo, Shuaihui Du, Yaling Zhang, Qian Guo, Lihua ZhouDepartment of VIP Clinic Nursing, West China Second University Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic
Zhang Y, Luo L, Du S, Zhang Y, Guo Q, Zhou L   +5 more
doaj  

How path integration abilities of blind people change in different exploration conditions

Frontiers in Neuroscience
For animals to locate resources and stay safe, navigation is an essential cognitive skill. Blind people use different navigational strategies to encode the environment.
Shehzaib Shafique, Walter Setti, Claudio Campus, Silvia Zanchi, Alessio Del Bue, Monica Gori   +5 more
doaj   +1 more source

Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients

British Journal of Clinical Pharmacology, EarlyView.
Aim Cisplatin causes acute kidney injury (AKI) in approximately 46% of paediatric cancer patients who receive it. Serum creatinine (SCr) is a poor biomarker of cisplatin nephrotoxicity, because there is a delay between cisplatin infusion and SCr elevation.
Yong Jin Lim, Amy Thachil, Kelly McMahon, Ross T. Tsuyuki, S. Rod Rassekh, Lesley G. Mitchell, Prasad Devarajan, Cherry Mammen, Bruce C. Carleton, Geoffrey D. E. Cuvelier, Victor A. Lewis, Colin J. D. Ross, Alexandra P. Zorzi, Sylvain Baruchel, Raveena Ramphal, Eric Bouffet, Mathieu Lemaire, Tom D. Blydt‐Hansen, Brad L. Urquhart, The Applying Biomarkers to Minimize Long‐Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group, Tom Blydt‐Hansen, Bruce C. Carleton, Geoff D. E. Cuvelier, Sunil Desai, Prasad Devarajan, Conrad Fernandez, Adam Fleming, Paul Gibson, Caroline Laverdiere, Victor Lewis, Mary L. McBride, Bruno Michon, Shahrad Rod Rassekh, Colin J. D. Ross, Christine Sabapathy, Kirk R. Schultz, Michael Zappitelli, Alexandra Zorzi   +37 more
wiley   +1 more source

Survival Outcomes With Cadonilimab Versus PD‐(L)1 Therapy in Front‐Line Gastric Cancer: A Network Meta‐Analysis

Cancer Reports
Background The FDA Oncologic Drugs Advisory Committee (ODAC) highlighted that the risk–benefit profile for patients with low PD‐L1 expression remains unclear in front‐line treatment of HER2‐negative gastric and gastroesophageal junction (GC/GEJ) cancer ...
Zi‐Kun Yu, Jia‐Hong Yi, Ju Xue, Yu‐Chen Huang, Yue Zhao, Chang Jiang, Chen‐Xi Yin, Biao Xia, Yi‐Xin Zhou, Wen‐Zhuo He, Liang‐Ping Xia   +10 more
doaj   +1 more source

Balls, Strikes, and VIPs

AMA Journal of Ethics, 2001
Little-known trivia about famous patients. Virtual Mentor is a monthly bioethics journal published by the American Medical Association.
openaire   +2 more sources

VIP attenuates NFAT activation.

, 2017
A) VIP administration inhibited CH-induced NFAT activation in isolated mouse intrapulmonary arteries. RLU = relative luciferase units. N = normoxia, CH V = 2 days chronic hypoxia. CH VIP = VIP (0.166 mg/kg/day) in osmotic pump one day prior and during CH
Jonathan C. Li (3710521), Anthony M. Szema (586328), Sayyed A. Hamidi (586329), Benjamin Ying (3710509), Wieslawa Giermakowska (3710512), Laura V. Gonzalez Bosc (3710518), Debra Sabatini Dwyer (3710527), Edward Forsyth (3710515), John J. Chen (353023), Juan M. Ramiro-Diaz (3710524), Sonya Hwang (3710506)   +10 more
core   +1 more source

Biomaterials for modulating cellular responses of endogenous tendon stem/progenitor cells: A promising avenue for tendon regeneration

BMEMat, EarlyView.
This review comprehensively summarizes emerging biomaterial‐based strategies and underlying mechanisms for modulating endogenous tendon stem/progenitor cells (TSPCs). It offers the most recent insights into TSPC physiology and potential applications of tissue engineering and regenerative medicine in tendons.
Zeyu Zhu, Renwang Sheng, Mumin Cao, Ludvig J. Backman, Yucheng Gao, Hao Wang, Cheng Zhang, Jialin Chen, Wei Zhang, Yunfeng Rui   +9 more
wiley   +1 more source

VIP impairs acquisition of the macrophage proinflammatory polarization profile

, 2016
This study tested the hypothesis that vasoactive intestinal peptide (VIP) is able to modify the macrophage inflammatory profile, thus supporting its therapeutic role in autoimmune diseases.
Puig-Kröger, Amaya, Carrión Caballo, Mar, Juarranz Moratilla, Yasmina, Pérez García, Selene, Pérez Gomáriz, Rosa María, Martínez Mora, María Del Carmen, Estrada Capetillo, Lizbeth, Gutiérrez Cañas, Irene   +7 more
core   +1 more source

A bioinspired catalytic nanoplatform for ferroptosis‐immunotherapy synergy in metastatic cancer

BMEMat, EarlyView.
The bioinspired nanoplatform MnMSN@MnP‐PEG co‐delivers manganese peroxidase and manganese ions to synergistically induce immunogenic ferroptosis and activate the cGAS‐STING pathway, eliciting potent antitumor immunity against primary and metastatic tumors.
Panpan Xue, Hai Cai, Ying Sun, Yaxin Ma, Siyuan Liu, Jinying Zhu, Yan Chen, Xuemei Zeng, Shuangqian Yan   +8 more
wiley   +1 more source